Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.22 USD | +1.83% | +37.04% | -66.83% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.34M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.56
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.51% |
Latest transcript on Processa Pharmaceuticals, Inc.
1 day | +1.83% | ||
1 week | +37.04% | ||
Current month | +1.83% | ||
1 month | -5.53% | ||
3 months | -5.13% | ||
6 months | -68.73% | ||
Current year | -66.83% |
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.22 | +1.83% | 256,816 |
24-04-30 | 2.18 | +3.81% | 382,983 |
24-04-29 | 2.1 | -2.33% | 378,117 |
24-04-26 | 2.15 | -11.52% | 1,856,628 |
24-04-25 | 2.43 | +50.00% | 77,210,296 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.83% | 6.34M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- PCSA Stock